If you liked this article you might like

Jim Cramer's Top Takeaways: Zoetis, Idexx, Danaher, Fortive
Jim Cramer's 'Mad Money' Recap: Why Some Stocks Pass Earnings Test and Others Fail
Analyst: Merck's Fundamentals Don't Warrant Current Valuation
Zoetis Stock Is Up to Scratch